# Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

> **NCT03161626** · — · COMPLETED · sponsor: **Bio Products Laboratory** · enrollment: 3 (actual)

## Conditions studied

- Factor 10 Deficiency

## Interventions

- **DRUG:** Coagadex

## Key facts

- **NCT ID:** NCT03161626
- **Lead sponsor:** Bio Products Laboratory
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2021-10-13
- **Final completion:** 2021-10-13
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03161626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03161626, "Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03161626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*